Drug intelligence / Profile preview

Bifiform

Development stage: Unknown
Lead developer: Pfizer
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Bifiform is a probiotic combination product designed to restore and maintain the balance of the intestinal microbiota. It typically contains live cultures of two symbiotic bacterial strains: *Bifidobacterium longum* and *Enterococcus faecium*. The mechanism of action involves the direct antagonism of pathogenic and opportunistic microorganisms within the gastrointestinal tract, alongside the stimulation of local intestinal immunity. By colonizing the gut, these bacteria help normalize the quantitative and qualitative composition of the microflora, which is often disrupted during illness or antibiotic treatment. Bifiform is primarily indicated for the treatment and prevention of dysbacteriosis, acute diarrhea, and various chronic gastrointestinal disorders. It is available in multiple formulations, including enteric-coated capsules designed to protect the live bacteria from gastric acid, as well as powder sachets and oral solutions tailored for different age groups.

Brand names: Bifiform

Beyond the preview

Go deeper on Bifiform.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bifiform.

Explore the full profile